Jeremy Grushcow earned a Ph.D. in Molecular Genetics and Cell Biology and a J.D. with Honors from the University of Chicago. He served as Chief Business Officer at Sequence Bio and as Executive Vice President of Strategic Development at Antibe Therapeutics, where he managed corporate partnerships and clinical development programs.
Intro paths
YC
Jeremy went through Y Combinator (Summer 2019) — any YC alum in your network can reach them through the YC community.
→
In turn, Jeremy can intro founders to Sequence Bio's investors below.
Sequence Bio's investors · 1
Co-founders
Chris Gardner· FounderLynn Healey· Chief Executive OfficerTom Barber· Chief Scientific Officer